High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

B cell receptor (BCR) sequencing is a powerful tool for interrogating immune responses to infection and vaccination, but it provides limited information about the antigen specificity of the sequenced BCRs. Here, we present LIBRA-seq (linking B cell receptor to antigen specificity through sequencing)...

Full description

Saved in:
Bibliographic Details
Published inCell Vol. 179; no. 7; pp. 1636 - 1646.e15
Main Authors Setliff, Ian, Shiakolas, Andrea R., Pilewski, Kelsey A., Murji, Amyn A., Mapengo, Rutendo E., Janowska, Katarzyna, Richardson, Simone, Oosthuysen, Charissa, Raju, Nagarajan, Ronsard, Larance, Kanekiyo, Masaru, Qin, Juliana S., Kramer, Kevin J., Greenplate, Allison R., McDonnell, Wyatt J., Graham, Barney S., Connors, Mark, Lingwood, Daniel, Acharya, Priyamvada, Morris, Lynn, Georgiev, Ivelin S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 12.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:B cell receptor (BCR) sequencing is a powerful tool for interrogating immune responses to infection and vaccination, but it provides limited information about the antigen specificity of the sequenced BCRs. Here, we present LIBRA-seq (linking B cell receptor to antigen specificity through sequencing), a technology for high-throughput mapping of paired heavy- and light-chain BCR sequences to their cognate antigen specificities. B cells are mixed with a panel of DNA-barcoded antigens so that both the antigen barcode(s) and BCR sequence are recovered via single-cell next-generation sequencing. Using LIBRA-seq, we mapped the antigen specificity of thousands of B cells from two HIV-infected subjects. The predicted specificities were confirmed for a number of HIV- and influenza-specific antibodies, including known and novel broadly neutralizing antibodies. LIBRA-seq will be an integral tool for antibody discovery and vaccine development efforts against a wide range of antigen targets. [Display omitted] •LIBRA-seq: high-throughput mapping of BCR sequence to antigen specificity•Identified HIV- and influenza-specific B cells in two HIV-infected subjects•Predicted antigen reactivity for thousands of single B cells•Identified a previously unknown broadly neutralizing HIV antibody LIBRA-seq enables high-throughput mapping of B cell receptor sequence to antigen specificity at the single-cell level.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current Address: 10X Genomics, Inc, Pleasanton, CA, USA
Author Contributions
Conception of LIBRA-seq technology, I.S.; Conceptualization, I.S., A.R.S., I.S.G.; Methodology, I.S., R.S., I.S.G.; Investigation, I.S., A.R.S., K.A.P., A.A.M., R.M., S.R., C.O., N.R., A.R.G., K.J., K.J.K., J.Q., D.L., L.R., W.J.M., I.S.G.; Software, I.S., N.R.; Validation, I.S., A.R.S, N.R.; Writing – Original Draft, I.S., A.R.S..; Writing – Review & Editing, All authors; Funding Acquisition, I.S.G., D.L., L.M., P.A., M.C., B.S.G., I.S.; Resources, M.K., P.A., B.S.G., M.C., D.L., L.R., L.M., I.S.G.; Supervision, I.S.G., L.M., P.A.
These authors contributed equally
ISSN:0092-8674
1097-4172
1097-4172
DOI:10.1016/j.cell.2019.11.003